How many insider trades does FilingIQ track for GRTX?

FilingIQ tracks 129 Form 4 insider transactions for GRTX (Galera Therapeutics, Inc.), covering filings from Apr 17, 2014 onwards. 4 of those were filed in the last 90 days.

Are GRTX insiders net buyers or net sellers?

Across the full Form 4 history for GRTX, 52 transactions (40%) were open-market purchases and 33 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GRTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GRTX in?

Galera Therapeutics, Inc. (GRTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.55M.

GRTX insider trading

OTC Markets OTCQB Healthcare

Galera Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

129

Last 90 days

Buys / sells

40% / 26%

Market cap

$3.55M

About Galera Therapeutics, Inc.

Galera Therapeutics, Inc., a biopharmaceutical company, focuses on the development of a portfolio of small molecule dismutase (SOD) mimetics to improve radiotherapy in cancer. The company's lead product is tilarginine that is in Phase 1/2 trial of a pan-inhibitor of nitric oxide synthase to treat patients with highly resistant forms of breast cancer, including metaplastic breast cancer (MpBC) and other refractory subsets of triple-negative breast cancer (TNBC). It develops avasopasem manganese, a small molecule dismutase mimetic for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC). The company was incorporated in 2012 and is based in Malvern, Pennsylvania.

Company website: www.galeratx.com

GRTX insider activity at a glance

FilingIQ has scored 129 insider transactions for GRTX since Apr 17, 2014. The most recent filing in our index is dated Apr 7, 2026.

Across the full history, 52 open-market purchases and 33 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GRTX insider trades is 51.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GRTX trades on FilingIQ Raw filings on SEC EDGAR

Latest GRTX Form 4 filings

Sorensen Mel President and CEO

S Nov 20, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for GRTX?: FilingIQ tracks 129 Form 4 insider transactions for GRTX (Galera Therapeutics, Inc.), covering filings from Apr 17, 2014 onwards. 4 of those were filed in the last 90 days.
Are GRTX insiders net buyers or net sellers?: Across the full Form 4 history for GRTX, 52 transactions (40%) were open-market purchases and 33 (26%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GRTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is GRTX in?: Galera Therapeutics, Inc. (GRTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $3.55M.

Methodology & sources

Every GRTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.